Skip to main content

Alterations in Oral Cancer Gene Expression in Response to Melatonin | Chapter 12 | New Insights into Disease and Pathogen Research Vol. 3

Aims: Melatonin (MLT) exerts oncostatic effects on numerous tumour types presumably by inhibiting cell proliferation and promoting apoptosis. The primary aim of this study was to investigate melatonin-induced changes in gene expression patterns in two different oral squamous carcinoma cell lines (OSCC).

Methodology: This was a prospective non-randomized experimental study design that was conducted at Department of Biomedical Sciences at the University of Nevada, Las Vegas – School of Dental Medicine between May 2016 and March 2017. The SCC25 and CAL27 cell lines were cultured with and without MLT (10 ug/mL) for 72 hours, and total cellular RNA was isolated and converted to cDNA. The expression of 92 genes associated with the molecular mechanisms of cancer and four endogenous control genes were examined by qRT-PCR. The fold change with respect to control levels were calculated using the comparative method or delta-delta ddCt algorithm.

Results: Gene expression was compared between the untreated and treated cells, SCC25 and CAL27. Although 40% of the genes (n=37/92) in SCC25 cells demonstrated different expression levels, only six were outside the relative-fold change values observed with all other genes (PTEN, MAPK3K5, BCL2, TAGA2B, MAX, and NFKB-IA). In CAL27 cell over 70% (n=65/92) genes exhibited different expression levels, with only two outside the relative fold-change values observed with all other genes (MAPK3K5, FZD1).

Conclusion: MLT administration to oral cancer cells may induce substantial changes in the expression levels of genes associated with the molecular mechanisms of cancer. However, relatively few of these changes were outside the range of observed values. Therefore, continued analysis and verification of these results in other oral cancers may reveal common MLT-induced changed and provide insights into the potential mechanisms of MLT-induced oncostatic effects in oral cancers.

Author(s) Details

Arin Hartounian
Department of Clinical Sciences, School of Dental Medicine, University of Nevada, Las Vegas, 1700 W. Charleston Blvd., Las Vegas, Nevada, 89106, USA.

Guillermo Alessandro Retis
Department of Clinical Sciences, School of Dental Medicine, University of Nevada, Las Vegas, 1700 W. Charleston Blvd., Las Vegas, Nevada, 89106, USA.

Karl Kingsley
Department of Biomedical Sciences, School of Dental Medicine, University of Nevada, Las Vegas, 1001 Shadow Lane, Las Vegas, Nevada, 89106, USA.

Dr. Katherine Howard, PhD
Department of Biomedical Sciences, School of Dental Medicine, University of Nevada, Las Vegas, 1001 Shadow Lane, Las Vegas, Nevada, 89106, USA.

View Books: http://bp.bookpi.org/index.php/bpi/catalog/book/112
Labels:

Comments

Post a Comment

Popular posts from this blog

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system
Post a Comment
Read more

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)
Post a Comment
Read more

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent
Post a Comment
Read more